UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

PLoS pathogens, 2017-04, Vol.13 (4), p.e1006285-e1006285

2017

Volltextzugriff (PDF)

Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults

PLoS genetics, 2021-04, Vol.17 (4), p.e1009464

2021

Volltextzugriff (PDF)

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

PloS one, 2009-08, Vol.4 (8), p.e6687-e6687

2009

Volltextzugriff (PDF)

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

AIDS (London), 2009-06, Vol.23 (9), p.1109-1118

2009

Volltextzugriff (PDF)

Impact of HIV infection and HAART on serum lipids in men

JAMA : the journal of the American Medical Association, 2003-06, Vol.289 (22), p.2978

2003

Volltextzugriff (PDF)

Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated

Frontiers in immunology, 2023-01, Vol.13, p.1062067-1062067

2023

Volltextzugriff (PDF)

Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir

Journal of Virus Eradication, 2022-06, Vol.8 (2), p.100073, Article 100073

2022

Volltextzugriff (PDF)

Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003

AIDS (London), 2005-06, Vol.19 (9), p.953-960

2005

Volltextzugriff (PDF)

Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1

Journal of Virology, 2012-12, Vol.86 (24), p.13202-13216

2012

Volltextzugriff (PDF)

HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial

PloS one, 2017-06, Vol.12 (6), p.e0178594-e0178594

2017

Volltextzugriff (PDF)

Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART

PloS one, 2010-03, Vol.5 (3), p.e9852-e9852

2010

Volltextzugriff (PDF)

Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes

EBioMedicine, 2021-01, Vol.63, p.103175-103175, Article 103175

2021

Volltextzugriff (PDF)

Therapeutic Immunization with Human Immunodeficiency Virus Type 1 (HIV-1) Peptide-Loaded Dendritic Cells Is Safe and Induces Immunogenicity in HIV-1-Infected Individuals

Clinical and Vaccine Immunology, 2008-02, Vol.15 (2), p.284-292

2008

Volltextzugriff (PDF)

HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy

Clinical infectious diseases, 2014-11, Vol.59 (9), p.1312-1321

2014

Volltextzugriff (PDF)

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

The Journal of infectious diseases, 2021-02, Vol.223 (2), p.225-233

2021

Volltextzugriff (PDF)

Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus–1

Clinical infectious diseases, 2021-06, Vol.72 (11), p.e815-e824

2021

Volltextzugriff (PDF)

Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2153-e2163

2021

Volltextzugriff (PDF)

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for quantifying lenacapavir plasma concentrations: Application to therapeutic monitoring

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2023-11, Vol.1230, p.123905-123905, Article 123905

2023

Volltextzugriff (PDF)

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring

Journal of pharmaceutical and biomedical analysis, 2024-03, Vol.240, p.115932, Article 115932

2024

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus–Associated Chronic Inflammation

The Journal of infectious diseases, 2020-04, Vol.221 (10), p.1598-1606

2020

Volltextzugriff (PDF)

A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention

The Journal of infectious diseases, 2024-04

2024

Volltextzugriff (PDF)

Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2024-07, Vol.1241, p.124164, Article 124164

2024

Volltextzugriff (PDF)

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy

The Journal of infectious diseases, 2016-02, Vol.213 (4), p.556-560

2016

Volltextzugriff (PDF)

Plasma HIV-1 RNA Dynamics in Antiretroviral-Naive Subjects Receiving either Triple-Nucleoside or Efavirenz-Containing Regimens: ACTG A5166s

The Journal of infectious diseases, 2007-04, Vol.195 (8), p.1169-1176

2007

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(137)
Reviews
(2)

Sprache

Englisch
(139)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(112)
Life Sciences & Biomedicine
(106)
Humans
(102)
Infectious Diseases
(82)
Immunology
(68)
Male
(61)
Hiv
(57)
Adult
(56)
Female
(53)
Biological And Medical Sciences
(51)
Hiv Infections - Drug Therapy
(51)
Medical Sciences
(50)
Human Immunodeficiency Virus
(45)
Virology
(45)
Microbiology
(41)
Middle Aged
(39)
Viral Diseases
(39)
Human Viral Diseases
(38)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(35)
Anti-Hiv Agents - Therapeutic Use
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

Impact of HIV infection and HAART on serum lipids in men

Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated

Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir

Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003

Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1

HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial

Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART

Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes

Therapeutic Immunization with Human Immunodeficiency Virus Type 1 (HIV-1) Peptide-Loaded Dendritic Cells Is Safe and Induces Immunogenicity in HIV-1-Infected Individuals

HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus–1

Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for quantifying lenacapavir plasma concentrations: Application to therapeutic monitoring

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring

A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus–Associated Chronic Inflammation

A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention

Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy

Plasma HIV-1 RNA Dynamics in Antiretroviral-Naive Subjects Receiving either Triple-Nucleoside or Efavirenz-Containing Regimens: ACTG A5166s

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

Suchergebnisse filtern